Abstract
BackgroundEarly arthritis (EA) is one of the difficult patient groups with the right timing of disease modifying anti-rheumatismal drugs (DMARDs).ObjectivesTo assess long term outcome, drug free remission rates of patients...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
